Bionano Genomics COO Mark Oldakowski files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.Bionano Genomics COO Mark Oldakowski filed an initial beneficial ownership statement via EDGAR. The report discloses a stock option for 15,000 shares at an exercise price of $1.12, expiring on August 2, 2036. This information was published by Bionano Genomics Inc. on August 5, 2026.
- Bionano Genomics COO Mark Oldakowski filed an initial ownership report showing a stock option for 15,000 shares at $1.12, expiring Aug. 2, 2036. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bionano Genomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001745566-26-000008), on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here